PAVmed Inc. (PAVM)

NASDAQ: PAVM · IEX Real-Time Price · USD
0.996
-0.054 (-5.15%)
At close: Jun 24, 2022 4:00 PM
1.030
+0.034 (3.424%)
After-hours: Jun 24, 2022 7:46 PM EDT
-5.15%
Market Cap 87.61M
Revenue (ttm) 689,000
Net Income (ttm) -58.06M
Shares Out 87.97M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,172,883
Open 1.040
Previous Close 1.050
Day's Range 0.975 - 1.090
52-Week Range 0.820 - 9.700
Beta 0.24
Analysts Buy
Price Target 6.12 (+514.5%)
Earnings Date Aug 11, 2022

About PAVM

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo,... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Apr 28, 2016
Employees 89
Stock Exchange NASDAQ
Ticker Symbol PAVM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for PAVM stock is "Buy." The 12-month stock price forecast is 6.12, which is an increase of 514.52% from the latest price.

Price Target
$6.12
(514.52% upside)
Analyst Consensus: Buy
Stock Forecasts

News

PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

NEW YORK--(BUSINESS WIRE)---- $PAVM #PAVmed--PAVmed provides business update and preliminary first quarter 2022 financial results.

3 Short Squeeze Penny Stocks To Buy For Under $5 This Week

Short squeeze penny stocks to watch this week. The post 3 Short Squeeze Penny Stocks To Buy For Under $5 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols: APRNMDVL

3 Short Squeeze Penny Stocks To Buy For Under $5 This Week

Short squeeze penny stocks to watch this week. The post 3 Short Squeeze Penny Stocks To Buy For Under $5 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols: APRNMDVL

PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced a procedural update...

PAVmed to Hold a Business Update Conference Call on May 12, 2022

NEW YORK--(BUSINESS WIRE)---- $PAVM #businessupdate--PAVmed to hold a Business Update Conference Call on May 12, 2022.

PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results

NEW YORK--(BUSINESS WIRE)---- $PAVM #earnings--PAVmed provides business update and preliminary fourth quarter and full year 2021 financial results.

PAVmed Highlights First-In-Human Implantations of its PortIO Infusion System

PAVmed Inc (NASDAQ: PAVM) announced the successful implantation of its PortIO Intraosseous Infusion System in three patients as part of a first-in-human (FIH) clinical study of up to 40 patients. No com...

PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System

NEW YORK--(BUSINESS WIRE)---- $PAVM #PortIO--PAVmed announces successful first-in-human implantations of its PortIO™ Intraosseous Infusion System.

PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board

NEW YORK--(BUSINESS WIRE)---- $PAVM #DigitalHealth--PAVmed subsidiary Veris Health launches world-class technology advisory board.

PAVmed to Hold a Business Update Conference Call on March 29, 2022

NEW YORK--(BUSINESS WIRE)---- $PAVM #Healthcare--PAVmed to hold a business update conference call on March 29, 2022.

Why PAVmed Stock Plummeted on Wednesday

News of a fresh round of capital raising seems to be making some investors ill.

Veris Health Showcased in PAVmed Digital Health Virtual Investor Event

NEW YORK--(BUSINESS WIRE)---- $PAVM--Veris Health showcased in PAVmed Digital Health Virtual Investor Event.

PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer

NEW YORK--(BUSINESS WIRE)---- $PAVM--PAVmed Digital Health Subsidiary Veris Health appoints Sunny Webb as Chief Technology Officer.

PAVM Stock: One Big Reason Why PAVmed Is Plunging Today

Today, a relatively disappointing start to trading for a PAVmed subsidiary, Lucid Diagnostics, is driving some bearish price action. The post PAVM Stock: One Big Reason Why PAVmed Is Plunging Today appe...

Lucid Diagnostics Announces Pricing of Initial Public Offering

NEW YORK--(BUSINESS WIRE)---- $LUCD--Lucid Diagnostics announces pricing of Initial Public Offering.

Other symbols: LUCD

PAVmed Acquires EsophaCap Manufacturer CapNostics LLC

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed acquires EsophaCap manufacturer CapNostics LLC.

PAVmed to Host Digital Health Virtual Investor Event

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed to Host Digital Health Virtual Investor Event, Veris Health: Bringing Digital Health to Cancer Care.

Why PAVmed Shares Are Trading Higher Today

PAVmed Inc (NASDAQ: PAVM) is trading higher Thursday after the company announced its majority-owned subsidiary, Lucid Diagnostics, filed a registration statement for a proposed initial public offering. ...

These 2 Nasdaq Small Caps Just Got Big Boosts

In a rising market, these companies looked especially impressive.

Other symbols: VERI

PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed subsidiary, Lucid Diagnostics, files registration statement for proposed initial public offering.

PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development P...

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed subsidiary Veris Health joins Microsoft for startups global program and engages Loka as software development partner.

PAVmed to Participate in September Investor and MedTech Conferences

NEW YORK--(BUSINESS WIRE)---- $PAVM--PAVmed to participate in September investor and MedTech conferences.

Why Shares of PAVmed Were Down This Morning

Investors are growing impatient about a planned spinoff.

PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results. Conference call to be held today at 4:30 PM EDT.

PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers

NEW YORK--(BUSINESS WIRE)---- $pavm--PAVmed subsidiary Lucid Diagnostics launches first Lucid test centers. Patients undergoing esophageal precancer testing in Phoenix metro area.